Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-3 of 3
Keywords: RET
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma
Available to PurchaseAndreas M. Heilmann, Vivek Subbiah, Kai Wang, James X. Sun, Julia A. Elvin, Juliann Chmielecki, Steven I. Sherman, Ravi Murthy, Naifa L. Busaidy, Ishwaria Subbiah, Roman Yelensky, Chaitali Nangia, Jo-Anne Vergilio, Saad A. Khan, Rachel L. Erlich, Doron Lipson, Jeffrey S. Ross, Vincent A. Miller, Manisha H. Shah, Siraj M. Ali, Philip J. Stephens
Journal:
Oncology
Oncology (2016) 90 (6): 339–346.
Published Online: 21 May 2016
... consecutive medullary thyroid carcinoma cases to identify all four classes of genomic alterations, and outcome for an index patient was collected. Results: RET was mutated in 88% (30/34) of cases, with RET M918T being responsible for 70% (21/30) of the RET alterations. The other RET alterations were RET...
Journal Articles
5′-End RET Splicing: Absence of Variants in Normal Tissues and Intron Retention in Pheochromocytomas
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2002) 63 (1): 84–91.
Published Online: 16 August 2002
...Hervé Le Hir; Nicolas Charlet-Berguerand; Vittorio de Franciscis; Claude Thermes The Ret tyrosine kinase is implicated in neuronal cell survival, kidney development and tumorigenesis. Several 3′ and 5′ transcript variants have been described resulting from alternative splicing of the RET pre-mRNA...
Journal Articles
Relative Expression of the RET9 and RET51 Isoforms in Human Pheochromocytomas
Available to PurchaseSubject Area:
Oncology
Hervé Le Hir, Nicolas Charlet-Berguerand, Anne-Paule Gimenez-Roqueplo, Massimo Mannelli, Pierre-François Plouin, Vittorio de Franciscis, Claude Thermes
Journal:
Oncology
Oncology (2000) 58 (4): 311–318.
Published Online: 18 May 2000
...Hervé Le Hir; Nicolas Charlet-Berguerand; Anne-Paule Gimenez-Roqueplo; Massimo Mannelli; Pierre-François Plouin; Vittorio de Franciscis; Claude Thermes Activating mutations of the RET oncogene cause the inheritance of multiple endocrine neoplasia type 2 (MEN2). The RET pre-mRNA is spliced...